close icon-linkedin icon-twitter icon-facebook icon-mail icon-google-plus icon-search icon-phone icon-instagram
What are you looking for?
Article 24 Jun 2021

IAM Life Sciences 2021: Legal tech and biotech patents

Patents are a true form of capital: nice to have, hard to get and looking at others will rarely make you happy. Part of this equation is the impenetrable ‘patentese’ that one must embrace while drafting and analysing patents and patent applications. Is there a shortcut?
In its most disruptive form, AI has the potential to render the patent literature a standardised, machine-readable library, changing the tide for patent practitioners and refocusing the role of patents in biotech

IAM Life Sciences

NLO's patent attorney Dietmar Hertsen wrote this article for the 2021 edition of 'IAM Life Sciences: Key issues for senior life sciences executives 2021'. To read the full article, click on the link below.


This article first appeared in IAM Life Sciences: Key issues for senior life sciences executives 2021, a supplement to IAM, published by Globe Business Media Group - IP Division. To view the guide in full, please to the website of IAM